The Study on HElicobacter Pylori eradication in patients with HEPatic complications
Not Applicable
- Conditions
- Chronic liver diseases H. pylori infection
- Registration Number
- JPRN-UMIN000012196
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with history of hypersensitivity to lansoprazole, amoxicillin, and clarithromycin. 2. Patients being treated with atazanavir, rilpivirine, pimozide, preparation containing ergotamine and tadalafil. 3. Patients with liver or kidney diseases being treated with colchicine. 4. Patients with infectious mononucleosis. 5. Patients with severe renal impairment. 6. Woman during the first three months of pregnancy. 7. Patients whom the principal and/or sub-investigators judged inadequate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method